Tinzaparin is a low-molecular-weight heparin (LMWH) with antithrombotic properties. It has FDA-approved labeling for use in the treatment of acute symptomatic deep-vein thrombosis (DVT ...

The Chinese Medical Association has released new guidelines for diagnosing and treating Mycoplasma pneumoniae in children.

The Chinese Medical Association has released new guidelines for diagnosing and treating Mycoplasma pneumoniae in children. Addressing challenges like variable symptoms and rising antibiotic resistance ...

CorMedix Inc.'s DefenCath reduces catheter infections by 71%, but the limited market potential challenges long-term adoption.

Opens in a new tab or window SAN DIEGO -- For patients with traumatic bone fractures, there was no difference between oral aspirin and low-molecular-weight heparin (LMWH) injections as a bleeding ...

After heparin treatment, you'll need blood tests to monitor the dose. Low-molecular-weight heparin (LMWH). Your doctor can also give you heparin as a shot. But you won't need blood testing because ...

Artificial intelligence can improve intravenous nutrition for premature babies, a Stanford Medicine study has shown. The ...

The agent tinzaparin — a low–molecular weight heparin (LMWH) — appeared to have caused the alopecia, which reversed completely when enoxaparin, another LMWH, was substituted. Some ...

Patients need macronutrients, the molecular building blocks of protein, fat and carbohydrates; micronutrients such as vitamins, minerals and electrolytes; and medications such as heparin ...

Artificial intelligence can improve intravenous nutrition for premature babies, a Stanford Medicine study has shown.